广康生化
(300804)
| 流通市值：12.50亿 | | | 总市值：33.63亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 382,211,123.05 | 160,416,302.71 | 754,799,505.24 | 549,873,806.69 |
| 营业总成本 | 378,926,709.86 | 162,627,495.93 | 713,052,217.39 | 515,527,922.51 |
| 其他经营收益 | | | | |
| 营业利润 | 2,815,793.65 | -1,047,851.03 | 47,223,830.14 | 41,654,882.89 |
| 利润总额 | 1,110,374.62 | -1,710,914.64 | 42,586,059.79 | 38,839,928.83 |
| 净利润 | 4,209,974.5 | -382,759.37 | 40,417,901.23 | 34,821,061.29 |
| 每股收益 | | | | |
| 其他综合收益 | -1,017.57 | - | - | - |
| 综合收益总额 | 4,208,956.93 | -382,759.37 | 40,417,901.23 | 34,821,061.29 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 963,531,823.32 | 951,226,780.94 | 1,088,941,347.15 | 1,131,892,557.79 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,255,260,301.59 | 1,200,417,206.75 | 1,128,346,502.48 | 1,057,292,707.07 |
| 资产总计 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 | 2,189,185,264.86 |
| 流动负债: | | | | |
| 流动负债合计 | 580,941,823.9 | 506,672,994.46 | 636,987,414.06 | 572,303,677.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 275,824,948.81 | 277,097,322.6 | 212,200,432.05 | 255,117,661.97 |
| 负债合计 | 856,766,772.71 | 783,770,317.06 | 849,187,846.11 | 827,421,339.83 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,359,903,241.75 | 1,366,912,093.04 | 1,367,331,125.55 | 1,360,726,905.32 |
| 股东权益合计 | 1,362,025,352.2 | 1,367,873,670.63 | 1,368,100,003.52 | 1,361,763,925.03 |
| 负债和股东权益合计 | 2,218,792,124.91 | 2,151,643,987.69 | 2,217,287,849.63 | 2,189,185,264.86 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 240,819,531.59 | 102,433,170.49 | 591,247,385.52 | 433,089,078.12 |
| 经营活动现金流出小计 | 314,269,550.05 | 160,419,032.07 | 510,328,057.01 | 391,803,922.94 |
| 经营活动产生的现金流量净额 | -73,450,018.46 | -57,985,861.58 | 80,919,328.51 | 41,285,155.18 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 371,537,091.19 | 150,511,717.77 | 2,207,858,700.64 | 2,177,787,239.23 |
| 投资活动现金流出小计 | 242,653,125.13 | 165,194,415.07 | 2,353,548,308.38 | 2,031,434,628.34 |
| 投资活动产生的现金流量净额 | 128,883,966.06 | -14,682,697.3 | -145,689,607.74 | 146,352,610.89 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 189,528,115.71 | 124,480,411.5 | 381,175,721.74 | 327,301,378.77 |
| 筹资活动现金流出小计 | 134,306,380.68 | 101,255,790.44 | 265,973,707.35 | 187,425,922.81 |
| 筹资活动产生的现金流量净额 | 55,221,735.03 | 23,224,621.06 | 115,202,014.39 | 139,875,455.96 |
| 汇率变动对现金及现金等价物的影响 | -1,606,646.75 | -916,708.9 | 1,312,615.26 | 1,389,431.87 |
| 现金及现金等价物净增加额 | 109,049,035.88 | -50,360,646.72 | 51,744,350.42 | 328,902,653.9 |
| 期末现金及现金等价物余额 | 282,509,054.11 | 123,099,371.51 | 173,460,018.23 | 451,390,789.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 109,049,035.88 | - | 51,744,350.42 | - |